Target Area:
Antihistamine therapy, appetite modulation
Buclizine is an established antihistamine with additional pharmacological effects relevant to appetite and metabolic regulation.
Our development efforts focus on efficient synthetic routes and cost-effective manufacturing strategies, enabling competitive supply for established therapeutic markets.
"Aurapha’s science-driven approach to API development demonstrates how rigorous chemistry, process robustness, and regulatory readiness can translate complex molecules into reliable, scalable drug substances."